Search results
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal, says report - CNBC TV18
CNBC TV18· 3 days agoLilly counts its IBD drug, Omvoh, among its future growth drivers, besides its blockbuster weight...
Eli Lilly to buy bowel disease drug developer Morphic for $3.2 bln - ET HealthWorld | Pharma
The Economic Times· 3 days agoLondon: Eli Lilly will acquire Morphic Holding for $3.2 billion in cash, the companies said on...
Lilly to buy Morphic in $3B bet on inflammation drug
BioPharma Dive· 3 days agoThe deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel...
Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition
Pharmaceutical Technology· 3 days agoEli Lilly has signed a definitive agreement to acquire Morphic Holding for $3.2bn, expanding its...
Most patients stop using Wegovy, Ozempic for weight loss within two years, analysis finds - ET...
The Economic Times· 1 day agoLondon: Only one in four U.S. patients prescribed Novo Nordisk's Wegovy or Ozempic for weight loss...
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss - ET...
The Economic Times· 2 days agoLondon: Shares in Novo Nordisk , maker of the wildly popular obesity drug Wegovy, were down 1.1 per...
Eli Lilly weight loss drug beats Ozempic in head-to-head study - ET HealthWorld | Pharma
The Economic Times· 2 days agoWashington: Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss...
14 Lilly Pulitzer Dresses Under $100 That Are Perfect for Summer
Woman's World· 3 days agoGet this look and more for under $100 at Zappos! Questions? Reach us at shop@womansworld.com Lilly...
The Lesbian Sex Scenes in Bound Seemed So Real the Movie Was Almost Rated NC-17
them· 6 days agoNot only does it mark the directorial debut for Lilly and Lana Wachowski, but it’s also a fantastic...
Pfizer moves forward with once-daily weight loss pill
CNBC Awaaz· 2 hours agoThe Pfizer drug is part of the second-generation of weight loss pills, under development by...